FindTrial
Sign In

Effects of histidine supplement on obese females: a randomized controlled trial

Effects of histidine supplement on obese females: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001551
Enrollment
Unknown
Registered
2011-09-08
Start date
2011-01-03
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Placebo:Placebo treatment
Histidine:Histidine supplement

Sponsors

Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: BMI>28, age 20-65, female

Exclusion criteria

Exclusion criteria: pregnant, diabetes

Design outcomes

Primary

MeasureTime frame
CRP, insulin, blood glucose, lipid;—

Secondary

MeasureTime frame
fatty acids, liver enzym;—

Countries

China

Contacts

Public ContactSun Changhao
changhao2002sun@gmail.com+86 0451 87502801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026